相关实验视频
Updated: Jun 18, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
基于结构的识别新型素脱乙酶4 (HDAC4) 抑制剂
Rupesh Agarwal1,2, Pawat Pattarawat3, Michael R Duff2
1UT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA.
Pharmaceuticals (Basel, Switzerland)
|July 27, 2024
概括
研究人员使用分子建模识别了癌症标HDAC4上的新口袋. 这导致发现了选择性抑制HDAC4的化合物,为癌症药物开发提供了新的策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 基因组脱乙酶 (HDACs) 是癌症治疗中的关键点.
- 目前FDA批准的HDAC抑制剂由于在HDAC类中保留了催化口袋,缺乏特异性.
- 针对特定类别的口袋对于开发更精确的癌症药物至关重要.
研究的目的:
- 识别和准IIa类HDAC中的新型,类特定的口袋,重点关注HDAC4.4.
- 发现与这些独特的口袋结合的小分子,与现有的抑制剂相比,提供了不同的作用机制.
- 评估已识别的化合物对HDAC4和其他HDAC的选择性和有效性,以及在癌症细胞系中.
主要方法:
- 利用分子建模和集体对接来选针对 HDAC4.4 中潜在的全囊向化合物的化合物.
- 员工共识评分,以优先考虑潜在的药物候选者.
- 进行了实验性结合试验,以比较化合物活性与HDAC4和HDAC3.
- 评估了活性化合物的有效性在人类乳腺和尿癌细胞系中.
主要成果:
- 在HDAC4-NCoR接口上发现了特定于HDAC4的新型口袋.
- 化合物88402可以选择性地抑制HDAC4,但不能抑制HDAC3.
- 化合物67436和134199显示HDAC4的微分子IC50值较低,与SAHA相似,但对HDAC3显著较弱,表明选择性有限.
- 五种化合物对人类乳腺癌和/或尿癌细胞系表现出活性.
结论:
- 该研究提出了一种开发选择性HDAC4抑制剂的新策略,通过针对特定类别的口袋来开发选择性HDAC4抑制剂.
- 已识别的化合物为开发下一代HDAC向癌症治疗提供了化学基础.
- 这种方法可以通过提高药物特异性,导致更有效,更少的毒性癌症治疗.
相关概念视频
Histone Modification
13.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.2K
Heterochromatin
12.0K
The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
12.0K

